Market Research Logo

Plasma Fractionation

Plasma Fractionation

Plasma Fractionation market worldwide is projected to grow by US$11.4 Billion, driven by a compounded growth of 6.5%. Intravenous Immunoglobulins, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$10.9 Billion by the year 2025, Intravenous Immunoglobulins will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$522.6 Million to the region's size and clout in the next 5 to 6 years. Over US$532.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Intravenous Immunoglobulins will reach a market size of US$1 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.2% over the next couple of years and add approximately US$2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Bio Products Laboratory Ltd.; Biotest AG; China Biologic Products, Inc.; CSL Limited; Green Cross Corporation; Grifols SA; Japan Blood Products Organization; Kedrion SpA; LFB SA; Octapharma AG; Sanquin; Shanghai RAAS Blood Products Co., Ltd.; Shire PLC

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Plasma Fractionation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Plasma Fractionation Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Plasma Fractionation Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Plasma Fractionation Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Intravenous Immunoglobulins (Product) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Intravenous Immunoglobulins (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Intravenous Immunoglobulins (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Coagulation Factor Concentrates (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Coagulation Factor Concentrates (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Coagulation Factor Concentrates (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Albumin (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: Albumin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: Albumin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Protease Inhibitors (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Protease Inhibitors (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Protease Inhibitors (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Other Products (Product) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 17: Other Products (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 18: Other Products (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Hospitals & Clinics (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
TABLE 20: Hospitals & Clinics (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
TABLE 21: Hospitals & Clinics (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
TABLE 22: Clinical Research Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 23: Clinical Research Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 24: Clinical Research Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Academic Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
TABLE 26: Academic Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
TABLE 27: Academic Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Plasma Fractionation Market Share (in %) by Company: 2019 & 2025
TABLE 28: United States Plasma Fractionation Market Estimates and Projections in US$ Million by Product: 2018 to 2025
TABLE 29: Plasma Fractionation Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
TABLE 30: United States Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
TABLE 31: United States Plasma Fractionation Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 32: Plasma Fractionation Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
TABLE 33: Plasma Fractionation Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 34: Canadian Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
TABLE 35: Canadian Plasma Fractionation Historic Market Review by Product in US$ Million: 2009-2017
TABLE 36: Plasma Fractionation Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
TABLE 37: Canadian Plasma Fractionation Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 38: Plasma Fractionation Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 39: Canadian Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 40: Japanese Market for Plasma Fractionation: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
TABLE 41: Plasma Fractionation Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
TABLE 42: Japanese Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
TABLE 43: Japanese Demand Estimates and Forecasts for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
TABLE 44: Japanese Plasma Fractionation Market in US$ Million by End-Use: 2009-2017
TABLE 45: Plasma Fractionation Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 46: Chinese Plasma Fractionation Market Growth Prospects in US$ Million by Product for the Period 2018-2025
TABLE 47: Plasma Fractionation Historic Market Analysis in China in US$ Million by Product: 2009-2017
TABLE 48: Chinese Plasma Fractionation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 49: Chinese Demand for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
TABLE 50: Plasma Fractionation Market Review in China in US$ Million by End-Use: 2009-2017
TABLE 51: Chinese Plasma Fractionation Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Plasma Fractionation Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 52: European Plasma Fractionation Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 53: Plasma Fractionation Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 54: European Plasma Fractionation Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 55: European Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018-2025
TABLE 56: Plasma Fractionation Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
TABLE 57: European Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
TABLE 58: European Plasma Fractionation Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 59: Plasma Fractionation Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 60: European Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
TABLE 61: Plasma Fractionation Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 62: French Plasma Fractionation Historic Market Scenario in US$ Million by Product: 2009-2017
TABLE 63: French Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
TABLE 64: Plasma Fractionation Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
TABLE 65: French Plasma Fractionation Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 66: French Plasma Fractionation Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
GERMANY
TABLE 67: Plasma Fractionation Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
TABLE 68: German Plasma Fractionation Historic Market Analysis in US$ Million by Product: 2009-2017
TABLE 69: German Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
TABLE 70: Plasma Fractionation Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 71: German Plasma Fractionation Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 72: Plasma Fractionation Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
TABLE 73: Italian Plasma Fractionation Market Growth Prospects in US$ Million by Product for the Period 2018-2025
TABLE 74: Plasma Fractionation Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
TABLE 75: Italian Plasma Fractionation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 76: Italian Demand for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
TABLE 77: Plasma Fractionation Market Review in Italy in US$ Million by End-Use: 2009-2017
TABLE 78: Italian Plasma Fractionation Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 79: United Kingdom Market for Plasma Fractionation: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
TABLE 80: Plasma Fractionation Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
TABLE 81: United Kingdom Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
TABLE 82: United Kingdom Demand Estimates and Forecasts for Plasma Fractionation in US$ Million by End-Use: 2018 to 2025
TABLE 83: United Kingdom Plasma Fractionation Market in US$ Million by End-Use: 2009-2017
TABLE 84: Plasma Fractionation Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 85: Rest of Europe Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018-2025
TABLE 86: Plasma Fractionation Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
TABLE 87: Rest of Europe Plasma Fractionation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
TABLE 88: Rest of Europe Plasma Fractionation Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 89: Plasma Fractionation Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 90: Rest of Europe Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 91: Plasma Fractionation Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 92: Asia-Pacific Plasma Fractionation Historic Market Scenario in US$ Million by Product: 2009-2017
TABLE 93: Asia-Pacific Plasma Fractionation Market Share Analysis by Product: 2009 VS 2019 VS 2025
TABLE 94: Plasma Fractionation Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
TABLE 95: Asia-Pacific Plasma Fractionation Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 96: Asia-Pacific Plasma Fractionation Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
REST OF WORLD
TABLE 97: Rest of World Plasma Fractionation Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
TABLE 98: Rest of World Plasma Fractionation Historic Market Review by Product in US$ Million: 2009-2017
TABLE 99: Plasma Fractionation Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
TABLE 100: Rest of World Plasma Fractionation Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 101: Plasma Fractionation Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 102: Rest of World Plasma Fractionation Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
IV. COMPETITION
BIO PRODUCTS LABORATORY
BIOTEST AG
CSL
CHINA BIOLOGIC PRODUCTS
GREEN CROSS CORPORATION
GRIFOLS SA
JAPAN BLOOD PRODUCTS ORGANIZATION
KEDRION SPA
LFB SA
OCTAPHARMA AG
SANQUIN BLOOD SUPPLY
SHANGHAI RAAS BLOOD PRODUCTS
SHIRE PLC
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report